8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6432976B1 · kind B1 · utility
3Cited by
8References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2000 |
| Grant date | Aug 13, 2002 |
| Priority date | — |
| Expiry date | Oct 25, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel 3-substituted 8-aza-bicyclo[3.2.1]octanes (commonly known as “tropanes”) substituted in the 8-position are effective as NMDA NR2B antagonists useful for relieving pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.